PL353064A1 - Novel chalcones - Google Patents

Novel chalcones

Info

Publication number
PL353064A1
PL353064A1 PL00353064A PL35306400A PL353064A1 PL 353064 A1 PL353064 A1 PL 353064A1 PL 00353064 A PL00353064 A PL 00353064A PL 35306400 A PL35306400 A PL 35306400A PL 353064 A1 PL353064 A1 PL 353064A1
Authority
PL
Poland
Prior art keywords
medicament
prevention
manufacture
useful
treatment
Prior art date
Application number
PL00353064A
Other languages
English (en)
Polish (pl)
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL353064A1 publication Critical patent/PL353064A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL00353064A 1999-09-03 2000-08-28 Novel chalcones PL353064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones
PCT/EP2000/008366 WO2001017988A1 (en) 1999-09-03 2000-08-28 Novel chalcones

Publications (1)

Publication Number Publication Date
PL353064A1 true PL353064A1 (en) 2003-10-06

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353064A PL353064A1 (en) 1999-09-03 2000-08-28 Novel chalcones

Country Status (21)

Country Link
US (1) US6620842B2 (https=)
EP (1) EP1212315B1 (https=)
JP (1) JP2003508527A (https=)
KR (1) KR100819576B1 (https=)
CN (1) CN1177843C (https=)
AT (1) ATE235483T1 (https=)
AU (1) AU776226B2 (https=)
CA (1) CA2382130A1 (https=)
CZ (1) CZ2002787A3 (https=)
DE (1) DE60001851T2 (https=)
DK (1) DK1212315T3 (https=)
ES (1) ES2193106T3 (https=)
GB (1) GB9920910D0 (https=)
HK (1) HK1043999B (https=)
HU (1) HUP0202579A3 (https=)
NO (1) NO20021049L (https=)
PL (1) PL353064A1 (https=)
PT (1) PT1212315E (https=)
RU (1) RU2252938C2 (https=)
SK (1) SK3112002A3 (https=)
WO (1) WO2001017988A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ536190A (en) 2002-04-17 2007-08-31 Cytokinetics Inc Compounds for treating cellular proliferative diseases by modulating the activity of the mitotic kinesin KSP
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
DE60326248D1 (de) 2002-07-17 2009-04-02 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
WO2013127361A1 (en) * 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634994B2 (en) * 1988-12-21 1993-03-11 Pharmacia & Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
CA2084208A1 (en) * 1990-05-17 1991-11-18 Barry Markaverich Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
CA2382130A1 (en) 2001-03-15
CN1371372A (zh) 2002-09-25
HUP0202579A2 (hu) 2002-11-28
SK3112002A3 (en) 2003-10-07
PT1212315E (pt) 2003-08-29
DE60001851D1 (de) 2003-04-30
CZ2002787A3 (cs) 2002-06-12
WO2001017988A1 (en) 2001-03-15
NO20021049L (no) 2002-05-03
AU776226B2 (en) 2004-09-02
KR100819576B1 (ko) 2008-04-22
HK1043999B (en) 2003-08-15
ES2193106T3 (es) 2003-11-01
EP1212315B1 (en) 2003-03-26
EP1212315A1 (en) 2002-06-12
US6620842B2 (en) 2003-09-16
AU7510900A (en) 2001-04-10
GB9920910D0 (en) 1999-11-10
US20030055056A1 (en) 2003-03-20
HK1043999A1 (en) 2002-10-04
HUP0202579A3 (en) 2003-07-28
KR20020031598A (ko) 2002-05-02
DE60001851T2 (de) 2003-12-11
JP2003508527A (ja) 2003-03-04
RU2252938C2 (ru) 2005-05-27
ATE235483T1 (de) 2003-04-15
CN1177843C (zh) 2004-12-01
NO20021049D0 (no) 2002-03-01
DK1212315T3 (da) 2003-06-23

Similar Documents

Publication Publication Date Title
DE60038038D1 (en) Phosphonatverbindungen
IL188250A0 (en) Dosage unit for inhibiting ovulation comprising drospirenone and a complex between ethinyl estradiol and cyclodextrine
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
BG105270A (en) Tetrahydropyridoethers
AP2000001898A0 (en) Vitronectin receptor antagonists
GB9920910D0 (en) Novel chalcones
PT989973E (pt) Calconas possuindo actividade antiproliferativa
CA2384433A1 (en) Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
EP0838461A3 (en) Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
BG106428A (en) Pharmaceutical compositions for treating psoriasis
WO2003037269A3 (en) Di-, tri,- and tetra-peptides having antiangiogenic activity
ITBO990597A0 (it) Ortesi ortopedica per il trattamento di epicondiliti .
ES1039452U (es) Placa de osteotomia triple de cadera mejorada.
GR990200198U (en) Corset for protecting pelvis region from fractures
ZA200004651B (en) Xylitol compositions for treating upper respiratory conditions.

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed